![Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12888-019-2181-9/MediaObjects/12888_2019_2181_Fig3_HTML.png)
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text
![The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia - ScienceDirect The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332220309008-ga1.jpg)
The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia - ScienceDirect
![Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial - The Lancet Psychiatry Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/e9cf19ac-161e-4c8f-983f-87015685d116/gr1_lrg.gif)
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial - The Lancet Psychiatry
![Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services](https://journals.healio.com/cms/asset/ea371f8f-f5d7-4453-bc69-e13078e5b553/10.3928_02793695-20130709-01-table5.jpg)
Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services
![Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12888-019-2181-9/MediaObjects/12888_2019_2181_Fig2_HTML.png)
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text
![Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services](https://journals.healio.com/cms/asset/57133eb4-8d09-4e5c-997a-e052f15007e3/10.3928_02793695-20130709-01-table1.jpg)
Efficacy of Quetiapine Off-Label Uses: Data Synthesis | Journal of Psychosocial Nursing and Mental Health Services
![Popular drug Seroquel, first meant for schizophrenia, reveals 'off-label' issues - The Washington Post Popular drug Seroquel, first meant for schizophrenia, reveals 'off-label' issues - The Washington Post](https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/H4FJ24Q34II6RGHVZ3WPVB2BWY.jpg&w=1440)
Popular drug Seroquel, first meant for schizophrenia, reveals 'off-label' issues - The Washington Post
![P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS092493380005152X/resource/name/firstPage-S092493380005152Xa.jpg)
P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core
![Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/54131111-0636-4405-8112-24d76b464cfc/gr1_lrg.gif)